Understanding Hypermobility Spectrum Disorders with Dr. Linda Bluestein

Defining Joint Hypermobility and Laxity

• 💡 Joint hypermobility is defined as a greater than expected range of motion in one or more joints.
• 📌 It can be asymptomatic or problematic, varying significantly between individuals.
• ⚠️ Joint laxity or instability, where bones have difficulty maintaining proper alignment, is considered more clinically significant than hypermobility alone.

Prevalence and Diagnosis of Hypermobility

• 🎯 While up to 90% of elite ballet dancers may exhibit hypermobility, it's present in about 20% of the adult population.
• 🔑 The five-point questionnaire is a valuable screening tool for generalized joint hypermobility, focusing on historical and current range of motion.
• 🩺 The Beighton score can also be used, but has limitations due to its focus on specific joints and potential influence of age and sex.

Hypermobility Spectrum Disorders (HSD) and Hypermobile EDS

• 🧩 Hypermobility Spectrum Disorders (HSD) are a classification for individuals who exhibit features of hypermobility but do not meet the stricter criteria for hypermobile Ehlers-Danlos Syndrome (hEDS).
• ⚖️ HSD can sometimes be more impactful than hEDS, highlighting the importance of recognizing the spectrum of severity.
• 🧬 For hEDS, diagnosis involves joint hypermobility, skin changes (hyperextensibility, bruising, scarring), and signs of weak tissues (hernias, prolapse).
• 🔬 While other EDS subtypes have genetic markers, the genetic basis for hEDS is still unknown, with revised diagnostic criteria anticipated.

Associated Conditions and Symptoms

• ⚡ Dysautonomia, particularly Postural Orthostatic Tachycardia Syndrome (POTS), is common, characterized by symptoms like dizziness, heart palpitations upon standing, and significant fatigue.
• 🌡️ Temperature intolerance (heat or cold) is a frequent manifestation of dysautonomia.
• 🧠 Neurodivergence, including ADHD and autism, as well as conditions like migraines, Chiari malformations, and cranial nerve issues, are also more prevalent.
• 💨 Mast Cell Activation Syndrome (MCAS) can contribute to inflammation, allergic-like phenomena, and nervous system sensitization, often overlapping with GI issues and food intolerances.

Management and Treatment Strategies

• movement Movement is prioritized in treatment, focusing on safe and progressive physical activity to build strength and confidence, counteracting fear of movement (kinesiophobia).
• 📚 Education is crucial, including understanding central sensitization and nociplastic pain to help patients reframe their bodily experiences.
• 🍎 Nutrition should focus on whole foods, with personalized approaches to potential food intolerances and histamine levels.
• 😴 Sleep optimization is vital, addressing pain-related insomnia and potential underlying issues like sleep apnea.
• 🧘 Psychosocial support, addressing past trauma and building supportive networks, is essential for overall well-being.
• 💊 Modalities like vagus nerve stimulation, myofascial release, and acupuncture can be beneficial.
• 💊 Medications such as low-dose naltrexone, ketotifen, and cromolyn are often used for their anti-inflammatory and mast cell stabilizing properties.
• 🌟 Supplements like Vitamin D, magnesium, quercetin, and PEA may also be recommended.
• 📉 Deprescribing is important to manage polypharmacy and identify potential issues related to medication excipients.